The study of Zhang et al. confirmed that lncRNA HEPFAL plays a crucial role in promoting ferroptosis by decreasing the expression of SLC7A11, highlighting a therapeutic potential of lncRNA HEPFAL in HCC (Zhang X. et al., 2022). Here, HEPFAL is linked to hepatocellular carcinoma.